SILK
- Silk Road Medical, Inc
()
Overview
Company Summary
Silk Road Medical, Inc (SILK) is a medical device company that focuses on providing minimally invasive treatments for patients with vascular conditions. The company specializes in developing and commercializing innovative products to improve the treatment of diseases affecting the carotid artery, a major blood vessel in the neck.
Silk Road Medical's flagship product is called TransCarotid Artery Revascularization (TCAR) system, which is designed to treat carotid artery disease. This condition occurs when the carotid artery becomes narrowed or blocked, potentially leading to strokes or other cardiovascular complications. The TCAR system enables physicians to access and treat the carotid artery through a small incision near the collarbone, rather than through the groin, which is the traditional approach.
The TCAR procedure combines aspects of both traditional and minimally invasive techniques to provide a safe and effective treatment option. It involves temporarily reversing blood flow in the carotid artery to prevent stroke while placing a stent to restore normal blood flow. This approach minimizes the risk of dislodging plaque, reducing the chance of stroke during the procedure.
Silk Road Medical aims to improve patient outcomes by offering a less invasive alternative to older surgical methods that require larger incisions and longer recovery times. Their innovative technology not only enhances the safety and efficacy of treating carotid artery disease but also improves patient comfort and shortens hospital stays.
In addition to their focus on carotid artery disease, Silk Road Medical is actively engaged in research and development efforts to expand their product portfolio and address other vascular conditions. Their mission is to provide physicians with advanced tools and solutions that empower them to deliver better outcomes for their patients in a minimally invasive and patient-friendly manner.